Product Information
PULMICORT 1 MG/2 ML RESPULE is a brand product labeled by AstraZeneca Pharmaceuticals LP, priced at $9.8448 per ML under NDC 00186199004. Its NADAC has been published 463 times since Nov 28, 2013.
FDA first approved this application on Aug 8, 2000. Its Orange Book therapeutic-equivalence code is AN.
Strength
1 mg/2mL
Manufacturer
AstraZeneca Pharmaceuticals LPNDC
00186199004
Classification
Brand
Dosage Form
SUSPENSION
Route
RESPIRATORY (INHALATION)
Effective Date
4/22/2026
Active Ingredients
BUDESONIDEApproval Type
New Drug (NDA)
FDA Application
NDA020929FDA Approved
8/8/2000
TE Code
AN
On Market Since
9/17/2007
Pharmacological Classes
Price Statistics
The NADAC for PULMICORT 1 MG/2 ML RESPULE has been published 463 times since Nov 28, 2013, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $9.8448 per ML |
|---|---|
| All-time high | $10.0569 (Jun 14, 2017) |
| All-time low | $9.8129 (Jul 17, 2019) |
| 52-week high | $9.8720 |
| 52-week low | $9.8140 |
| Median price | $9.8559 |
| Average price | $9.8709 |
| Largest weekly change | +2.2% (Sep 21, 2016) |
| Weeks tracked | 463 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 65% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
AstraZeneca Pharmaceuticals LP manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Budesonide market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Corticosteroid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of PULMICORT 1 MG/2 ML RESPULE?
The current National Average Drug Acquisition Cost (NADAC) for PULMICORT 1 MG/2 ML RESPULE, manufactured by AstraZeneca Pharmaceuticals LP, is $9.8448 per ML (NDC 00186199004), effective Sep 30, 2026.
How has the price of PULMICORT 1 MG/2 ML RESPULE changed over time?
Over the history we have for it, the NADAC for PULMICORT 1 MG/2 ML RESPULE has held within roughly two percent of its current level. It has been tracked across 463 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for PULMICORT 1 MG/2 ML RESPULE?
Since Nov 28, 2013, the NADAC for PULMICORT 1 MG/2 ML RESPULE has ranged from a low of $9.8129 (Jul 17, 2019) to a high of $10.0569 (Jun 14, 2017), with a median of $9.8559 per ML.
Are there cheaper alternatives to PULMICORT 1 MG/2 ML RESPULE?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, BUDESONIDE 1 MG/2 ML INH SUSP, is $3.4274 per ML — about 65% below PULMICORT 1 MG/2 ML RESPULE.
Who manufactures PULMICORT 1 MG/2 ML RESPULE?
PULMICORT 1 MG/2 ML RESPULE (NDC 00186199004) is labeled by AstraZeneca Pharmaceuticals LP, and CMS classifies it as a brand product.